Status Unknown
Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid in Combination With Topical Hydroquinone for Refractory Melasma
Led by Egymedicalpedia · Updated on 2024-07-26
45
Participants Needed
1
Research Sites
1 weeks
Total Duration
AI-Summary
What this Trial Is About
Melasma is a common acquired disorder of hyperpigmentaion caused by increased melanin production by melanocytes. Melasma is a name derived from the Greek word melas meaning black.It is characterized by the appearance of brownish or grayish symmetrical patches on sun-exposed skin, most commonly on the face. Compared to men, women are more likely to be affected.
CONDITIONS
Brief Title
Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid
Research Team
H
Heba Allah Mohamed Mustafa, Resident
M
Moustafa Adam Ali El Taieb, professor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here